Japanese Journal of National Medical Services
Online ISSN : 1884-8729
Print ISSN : 0021-1699
ISSN-L : 0021-1699
CLINICAL SURVEY OF PHARMACOLOGIC THERAPY FOR EXACERBATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
NHO RESPIRATORY NETWORK IN KYUSHU AREA
Tomoaki IWANAGAShohei TAKATAShigeru MIYAGIMasaharu KAWABATANaoya OHTSUYoshiya KITAHARAKenji KAWAKAMIKenji HIGASHIToshiyuki OE
Author information
JOURNAL FREE ACCESS

2005 Volume 59 Issue 8 Pages 420-426

Details
Abstract
An exacerbation, a key clinical feature of chronic obstructive pulmonary disease (COPD), is characterized by an acute increase in patient symptoms during the course of their stable disease. It is crucial to treat this situation which is considered to be one of the most important markers of severity as well as of prognosis of this disease. By using multiple questionnaires in the national hospital network of respiratory diseases in Kyushu area, we investigated how pulmonologists manage these catastrophes in outpatient as well as in hospital. As a result, we found a considerable variation among them in terms of pharmacologic therapy. Short-acting beta2-agonists (SABA) were used variously from every 20 minutes to every 12 hours for mild exacerbations and from every 10 minutes to every 6 hours for severe ones. Systemic steroids were differently administered in doses of 10mg/day of prednisolone to more than 30mg/day for three days to over seven days in outpatient situations. They were injected in drip infusion for three to 14 days in hospitalized patients. Oral antibiotics were given for less than 5 days and up to 14 days in outpatients. Parenteral antibiotics were injected for 7 to 14 days. The optimal doses, frequency, and duration of these treatments remains uncertain. These results might be derived from the heterogeneous pathogenesis of exacerbations of this disease. Further studies are needed to determine the proper use of these drugs.
Content from these authors
© Japanese Society of National Medical Services
Previous article Next article
feedback
Top